EUVIMEDEUVIMED entdecken
Crossref

Long-term Patterns of Failure and the Value of Blood Prognostic Markers in Anal Cancers Treated With Intensity-Modulated Radiation Therapy

Joseph Sia, Wei Mou Lim, Ryan Anthony Agas, Jing Xie, Mark Burns, Nahal Varghayee, Julie Chu, Alexander Heriot, Trevor Leong, Samuel Y Ngan

Clinical Colorectal Cancer · 2022-06 · 21 (2) · e102-e112

DOI: 10.1016/j.clcc.2021.10.005 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Colorectal Cancer, 2022-06. Verfasst von Joseph Sia und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, Peter MacCallum Cancer Centre, Melbourne, Australia; Sir PeterMacCallum Department of Oncology, University of Melbo…. Hauptthemen laut MEDLINE: Anus Neoplasms, Radiotherapy, Intensity-Modulated. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 32 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: To analyze the long-term outcomes and prognostic value of hematological parameters in anal cancer patients receiving intensity-modulated radiation therapy (IMRT). MATERIALS: Hospital records of consecutive patients with anal squamous cell carcinoma who received curative-intent IMRT according to a standardized contouring protocol between 2010 and 2020 were reviewed. Locoregional failure-free survival (LRFS), distant metastasis-free survival (DMFS), progression-free survival (PFS), and overall survival (OS) were estimated using the Kaplan-Meier method. Coverage of locoregional recurrences by the initial IMRT volumes were assessed. The prognostic value of pretreatment blood counts for PFS and OS were determined using Cox regression analysis. RESULTS: A total of 166 patients were analyzed with a median follow-up of 3.3 years. Forty-six percent and 54% of patients had Stage I-II and IIIA-B cancers, respectively. The 5-year LRFS, DMFS, PFS and OS were 81%, 89%, 65% and 76% respectively. Grade ≥ 3 toxicity occurred in 5% of patients. Of all patients who relapsed, 70% had only locoregional recurrence as first site of failure. Ninety percent of locoregional recurrences were in-field. Hemoglobin, neutrophil and platelet counts were associated with PFS on univariable analysis, but only cancer stage and p16 status remained prognostic on multivariable analysis. Patients with more advanced cancer stages also had higher baseline neutrophil counts. Performance status and neutrophil counts were prognostic for OS on multivariable analysis. CONCLUSION: This study affirms the long-term efficacy and safety of IMRT. Treatment resistance, rather than radiation geographic miss, is a major issue underpinning locoregional recurrences. Pretreatment blood counts were not validated to be independently prognostic for disease recurrence.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Anus NeoplasmsRadiotherapy, Intensity-ModulatedDisease-Free SurvivalHumansNeoplasm Recurrence, LocalPrognosisRetrospective Studies

Stichwörter der Autor:innen

BiomarkersLocoregional recurrenceRadiotherapyRetrospective studyToxicity

Autor:innen und Institutionen

  • Department of Radiation Oncology, Peter MacCallum Cancer Centre, Melbourne, Australia; Sir PeterMacCallum Department of Oncology, University of Melbourne, Parkville, Australia. Electronic address: joseph.sia@petermac.or…
  • Department of Surgical Oncology, Peter MacCallum Cancer Centre, Melbourne, Australia; Sir PeterMacCallum Department of Oncology, University of Melbourne, Parkville, Australia.
  • Department of Radiation Oncology, Peter MacCallum Cancer Centre, Melbourne, Australia.
  • Centre for Biostatistics and Clinical Trials, Peter MacCallum Cancer Centre, Melbourne, Australia.
  • Department of Radiation Oncology, Peter MacCallum Cancer Centre, Melbourne, Australia; Sir PeterMacCallum Department of Oncology, University of Melbourne, Parkville, Australia.

Zitieren

APA

Sia, J., Lim, W. M., Agas, R. A., Xie, J., Burns, M., Varghayee, N., Chu, J., Heriot, A., Leong, T., & Ngan, S. Y. (2022). Long-term Patterns of Failure and the Value of Blood Prognostic Markers in Anal Cancers Treated With Intensity-Modulated Radiation Therapy. Clinical Colorectal Cancer, 21(2), e102-e112. https://doi.org/10.1016/j.clcc.2021.10.005

Vancouver

Sia J, Lim WM, Agas RA, Xie J, Burns M, Varghayee N, et al. Long-term Patterns of Failure and the Value of Blood Prognostic Markers in Anal Cancers Treated With Intensity-Modulated Radiation Therapy. Clinical Colorectal Cancer. 2022;21(2):e102-e112. doi:10.1016/j.clcc.2021.10.005

BibTeX
@article{Sia2022,
  author = {Sia, Joseph and Lim, Wei Mou and Agas, Ryan Anthony and Xie, Jing and Burns, Mark and Varghayee, Nahal and Chu, Julie and Heriot, Alexander and Leong, Trevor and Ngan, Samuel Y},
  title = {Long-term Patterns of Failure and the Value of Blood Prognostic Markers in Anal Cancers Treated With Intensity-Modulated Radiation Therapy},
  journal = {Clinical Colorectal Cancer},
  year = {2022},
  volume = {21},
  number = {2},
  pages = {e102--e112},
  doi = {10.1016/j.clcc.2021.10.005}
}
Kostenlos starten →